Board Meetings for MANKIND
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MANKIND | Mankind Pharma Limited | 19 May 2026 | Board Meeting Intimation | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 19-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Alteration of form or nature or rights of securities. | |
| MANKIND | Mankind Pharma Limited | 19 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 | |
| MANKIND | Mankind Pharma Limited | 03 Feb 2026 | Board Meeting Intimation | Mankind Pharma Limited has informed the Exchange about Board Meeting to be held on 03-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| MANKIND | Mankind Pharma Limited | 03 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 | |
| MANKIND | Mankind Pharma Limited | 06 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 | |
| MANKIND | Mankind Pharma Limited | 06 Nov 2025 | Board Meeting Intimation | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 . | |
| MANKIND | Mankind Pharma Limited | 31 Jul 2025 | Board Meeting Intimation | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 31-Jul-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Dividend. | |
| MANKIND | Mankind Pharma Limited | 31 Jul 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended Jun 30, 2025 and dividend | |
| MANKIND | Mankind Pharma Limited | 21 May 2025 | Board Meeting Intimation | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 . | |
| MANKIND | Mankind Pharma Limited | 21 May 2025 | Financial Results | Pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, May 21, 2025, inter-alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31, 2025.Further, in continuation of our earlier letter dated March 26, 2025 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's 'Code of Conduct for Prevention of Insider Trading', the trading window for trading in the securities of the Company shall remain closed till May 23, 2025 | |
| MANKIND | Mankind Pharma Limited | 23 Jan 2025 | Board Meeting Intimation | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| MANKIND | Mankind Pharma Limited | 23 Jan 2025 | Financial Results | To consider and approve the unaudited financial results for the quarter and nine months ended on December 31, 2024 | |
| MANKIND | Mankind Pharma Limited | 05 Nov 2024 | Financial Results | To consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2024 | |
| MANKIND | Mankind Pharma Limited | 05 Nov 2024 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 20 Sept 2024 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 20-Sep-2024 to consider Fund raising. | Board Meeting Intimation |
Showing page 1 of 2 (28 total items)